Bill Susanj is a seasoned executive leader with over 25 years of experience in the pharmaceutical industry. He is an expert in strategic planning, business insights, commercial operations, and advanced analytics that drive business growth. Susanj's expertise lies in utilizing data, analysis, technologies, strategies, and teams to reveal unprecedented insights into the evolving healthcare market and shape successful strategy. He is a pioneer in innovative pharmaceutical commercial models and leads business-critical projects.

Susanj's experience includes guiding a 30-member team in the development of a new commercial model for Novartis, delivering comprehensive insight into the evolution of the healthcare market to drive commercial success. He is well-versed in advanced analytics, data science, machine learning/AI, and predictive analytics applications, closely following technological advances and their implications for the pharmaceutical industry.

As part of his talent development and leadership skills, Susanj has successfully hired, managed, and mentored over 80 associates, developing the vast majority into positions of increased responsibility. He is also a leader of cross-functional data science and project teams. Additionally, Bill has a broad therapeutic expertise in Rx & OTC Consumer Research ranging from ADHD, Alzheimer, Cancer, and Diabetes to Sleep Disorders, Stroke, Transplantation, and more.

Susanj completed his Bachelor of Arts (BA) in Business Administration at Indiana University of Pennsylvania, a Bachelor of Arts (BA) in Liberal Arts from Thiel College, and two MBA degrees (MBA, Market Analytics and MBA) from the University of Pittsburgh - Joseph M. Katz Graduate School of Business. He has held various senior positions throughout his career, including Senior Vice President at Jupiter Life Science Consulting, Executive Director, Value & Access Practice Lead at Evidera, and SVP Consulting at Ipsos.